Cargando…
Ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the SYNTAX Extended Survival study
BACKGROUND: Coronary bypass artery grafting (CABG) has a higher procedural risk of stroke than percutaneous coronary intervention (PCI), but may offer better long-term survival. The optimal revascularization strategy for patients with prior cerebrovascular disease (CEVD) remains unclear. METHODS AND...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484131/ https://www.ncbi.nlm.nih.gov/pubmed/33517534 http://dx.doi.org/10.1007/s00392-020-01802-x |
_version_ | 1784577253566316544 |
---|---|
author | Wang, Rutao Takahashi, Kuniaki Garg, Scot Thuijs, Daniel J. F. M. Kappetein, Arie Pieter Mack, Michael J. Morice, Marie-Claude Mohr, Friedrich-Wilhelm Curzen, Nick Davierwala, Piroze Milojevic, Milan van Geuns, Robert Jan Head, Stuart J. Onuma, Yoshinobu Holmes, David R. Serruys, Patrick W. |
author_facet | Wang, Rutao Takahashi, Kuniaki Garg, Scot Thuijs, Daniel J. F. M. Kappetein, Arie Pieter Mack, Michael J. Morice, Marie-Claude Mohr, Friedrich-Wilhelm Curzen, Nick Davierwala, Piroze Milojevic, Milan van Geuns, Robert Jan Head, Stuart J. Onuma, Yoshinobu Holmes, David R. Serruys, Patrick W. |
author_sort | Wang, Rutao |
collection | PubMed |
description | BACKGROUND: Coronary bypass artery grafting (CABG) has a higher procedural risk of stroke than percutaneous coronary intervention (PCI), but may offer better long-term survival. The optimal revascularization strategy for patients with prior cerebrovascular disease (CEVD) remains unclear. METHODS AND RESULTS: The SYNTAXES study assessed the vital status out to 10 year of patients with three-vessel disease and/or left main coronary artery disease enrolled in the SYNTAX trial. The relative efficacy of PCI vs. CABG in terms of 10 year all-cause death was assessed according to prior CEVD. The primary endpoint was 10 year all-cause death. The status of prior CEVD was available in 1791 (99.5%) patients, of whom 253 patients had prior CEVD. Patients with prior CEVD were older and had more comorbidities (medically treated diabetes, insulin-dependent diabetes, metabolic syndrome, peripheral vascular disease, chronic obstructive pulmonary disease, impaired renal function, and congestive heart failure), compared with those without prior CEVD. Prior CEVD was an independent predictor of 10 year all-cause death (adjusted HR: 1.35; 95% CI: 1.04–1.73; p = 0.021). Patients with prior CEVD had a significantly higher risk of 10 year all-cause death (41.1 vs. 24.1%; HR: 1.92; 95% CI: 1.54–2.40; p < 0.001). The risk of 10 year all-cause death was similar between patients receiving PCI or CABG irrespective of the presence of prior CEVD (p(-interaction) = 0.624). CONCLUSION: Prior CEVD was associated with a significantly increased risk of 10 year all-cause death which was similar in patients treated with PCI or CABG. These results do not support preferential referral for PCI rather than CABG in patients with prior CEVD. Trial registration: SYNTAX: ClinicalTrials.gov reference: NCT00114972. SYNTAX Extended Survival: ClinicalTrials.gov reference: NCT03417050. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00392-020-01802-x. |
format | Online Article Text |
id | pubmed-8484131 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-84841312021-10-08 Ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the SYNTAX Extended Survival study Wang, Rutao Takahashi, Kuniaki Garg, Scot Thuijs, Daniel J. F. M. Kappetein, Arie Pieter Mack, Michael J. Morice, Marie-Claude Mohr, Friedrich-Wilhelm Curzen, Nick Davierwala, Piroze Milojevic, Milan van Geuns, Robert Jan Head, Stuart J. Onuma, Yoshinobu Holmes, David R. Serruys, Patrick W. Clin Res Cardiol Original Paper BACKGROUND: Coronary bypass artery grafting (CABG) has a higher procedural risk of stroke than percutaneous coronary intervention (PCI), but may offer better long-term survival. The optimal revascularization strategy for patients with prior cerebrovascular disease (CEVD) remains unclear. METHODS AND RESULTS: The SYNTAXES study assessed the vital status out to 10 year of patients with three-vessel disease and/or left main coronary artery disease enrolled in the SYNTAX trial. The relative efficacy of PCI vs. CABG in terms of 10 year all-cause death was assessed according to prior CEVD. The primary endpoint was 10 year all-cause death. The status of prior CEVD was available in 1791 (99.5%) patients, of whom 253 patients had prior CEVD. Patients with prior CEVD were older and had more comorbidities (medically treated diabetes, insulin-dependent diabetes, metabolic syndrome, peripheral vascular disease, chronic obstructive pulmonary disease, impaired renal function, and congestive heart failure), compared with those without prior CEVD. Prior CEVD was an independent predictor of 10 year all-cause death (adjusted HR: 1.35; 95% CI: 1.04–1.73; p = 0.021). Patients with prior CEVD had a significantly higher risk of 10 year all-cause death (41.1 vs. 24.1%; HR: 1.92; 95% CI: 1.54–2.40; p < 0.001). The risk of 10 year all-cause death was similar between patients receiving PCI or CABG irrespective of the presence of prior CEVD (p(-interaction) = 0.624). CONCLUSION: Prior CEVD was associated with a significantly increased risk of 10 year all-cause death which was similar in patients treated with PCI or CABG. These results do not support preferential referral for PCI rather than CABG in patients with prior CEVD. Trial registration: SYNTAX: ClinicalTrials.gov reference: NCT00114972. SYNTAX Extended Survival: ClinicalTrials.gov reference: NCT03417050. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00392-020-01802-x. Springer Berlin Heidelberg 2021-01-30 2021 /pmc/articles/PMC8484131/ /pubmed/33517534 http://dx.doi.org/10.1007/s00392-020-01802-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Paper Wang, Rutao Takahashi, Kuniaki Garg, Scot Thuijs, Daniel J. F. M. Kappetein, Arie Pieter Mack, Michael J. Morice, Marie-Claude Mohr, Friedrich-Wilhelm Curzen, Nick Davierwala, Piroze Milojevic, Milan van Geuns, Robert Jan Head, Stuart J. Onuma, Yoshinobu Holmes, David R. Serruys, Patrick W. Ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the SYNTAX Extended Survival study |
title | Ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the SYNTAX Extended Survival study |
title_full | Ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the SYNTAX Extended Survival study |
title_fullStr | Ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the SYNTAX Extended Survival study |
title_full_unstemmed | Ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the SYNTAX Extended Survival study |
title_short | Ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the SYNTAX Extended Survival study |
title_sort | ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the syntax extended survival study |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484131/ https://www.ncbi.nlm.nih.gov/pubmed/33517534 http://dx.doi.org/10.1007/s00392-020-01802-x |
work_keys_str_mv | AT wangrutao tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy AT takahashikuniaki tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy AT gargscot tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy AT thuijsdanieljfm tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy AT kappeteinariepieter tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy AT mackmichaelj tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy AT moricemarieclaude tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy AT mohrfriedrichwilhelm tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy AT curzennick tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy AT davierwalapiroze tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy AT milojevicmilan tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy AT vangeunsrobertjan tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy AT headstuartj tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy AT onumayoshinobu tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy AT holmesdavidr tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy AT serruyspatrickw tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy |